Our Approach

Ardelyx develops:

  • Drugs that target proteins found in the gut whose activities affect the entire body
  • Drugs that are not absorbed, enabling them to achieve systemic efficacy while avoiding systemic toxicity and side effects

What we do

Targeted Therapeutic Areas

Ardelyx has established a unique approach to drug development with programs targeting gut transporters, receptors, and enzymes

Therapeutic Areas

Partners

Strategy

As part of our financial goals and commercial strategy we will establish collaborations with the world’s major pharmaceutical and biotechnology companies. We recognize that such collaborations will leverage our capabilities to discover innovative small molecule drugs. For more information about partnering opportunities please contact Mark Kaufmann, Chief Business Officer; mkaufmann@ardelyx.com